JYL
from 200 today
We remain cautious on JYL's near-term outlook, with elevated competitive intensity and crude-linked raw material inflation expected to constrain both growth and margin. We reiterate our Neutral rating on the stock with a TP of INR210.
Jyothy Laboratories reported a weak 1QFY27 with a miss on revenue growth and a sharp contraction in margins due to elevated crude-linked raw material costs and intense competition. We reiterate our Neutral rating on the stock with a target price of INR210.
Ratings and target prices as published by each firm. Each summary condenses that firm's stated view in its own note and is attributed to it; no report text is reproduced.
